Credit Suisse’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.05M | Buy |
|
|||||
|
2023
Q4 | $1.57M | Buy |
|
|||||
|
2023
Q3 | $1.03M | Sell |
|
|||||
|
2023
Q2 | $1.72M | Buy |
|
|||||
|
2023
Q1 | $1.18M | Buy |
|
|||||
|
2022
Q4 | $1.39M | Buy |
|
|||||
|
2022
Q3 | $1.09M | Buy |
|
|||||
|
2022
Q2 | $630K | Buy |
|
|||||
|
2022
Q1 | $516K | Sell |
|
|||||
|
2021
Q4 | $670K | Buy |
|
|||||
|
2021
Q3 | $508K | Buy |
|
|||||
|
2021
Q2 | $411K | Sell |
|
|||||
|
2021
Q1 | $578K | Sell |
|
|||||
|
2020
Q4 | $1.24M | Sell |
|
|||||
|
2020
Q3 | $908K | Buy |
|
|||||
|
2020
Q2 | $770K | Buy |
|